Facet Royalties. Subject to Section 9.5(e) if Facet has exercised its Opt-Out Option pursuant to Section 7.2 Trubion shall pay Facet royalties on the Net Sales of Royalty Products during the applicable Royalty Period as follows: Within [ * ] after the [ * ] for the [ * ] [ * ] % Within [ * ] after the [ * ] for [ * ] [ * ] %
Appears in 2 contracts
Samples: Collaboration and License Agreement (Facet Biotech Corp), Collaboration and License Agreement (Trubion Pharmaceuticals, Inc)
Facet Royalties. Subject to Section 9.5(e) if Facet has exercised its Opt-Out Option pursuant to Section 7.2 Trubion shall pay Facet royalties on the Net Sales of Royalty Products during the applicable Royalty Period as follows: Within [ * ] after the [ * ] for the [ * ] [ * ] % Within [ * ] after the [ * ] for [ * ] [ * ] %]
Appears in 1 contract
Samples: Collaboration and License Agreement (Facet Biotech Corp)
Facet Royalties. Subject to Section 9.5(e) if Facet has exercised its Opt-Out Option pursuant to Section 7.2 Trubion shall pay Facet royalties on the Net Sales of Royalty Products during the applicable Royalty Period as follows: Within [ * [*] after the [ * [*] for the [ * [*] [ * ] % Within [ * ] after the [ * ] for [ * ] [ * ] %[*]
Appears in 1 contract
Samples: Collaboration and License Agreement (Trubion Pharmaceuticals, Inc)
Facet Royalties. Subject to Section 9.5(e) ), if Facet has is deemed pursuant to Section 14.2(b) to have exercised its Opt-Out Option pursuant with respect to Section 7.2 all Products on account of an uncured material breach by Facet, Trubion shall pay Facet royalties on the Net Sales of Royalty Products during the applicable Royalty Period Period, as follows: Within [ * [*] after the [ * [*] for the [ * [*] [ * [*] % Within [ * [*] after the [ * [*] for [ * [*] [ * [*] %[*] [*]
Appears in 1 contract
Samples: Collaboration and License Agreement (Trubion Pharmaceuticals, Inc)